These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 19560158
1. Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines. Pichichero ME, Gentile A, Giglio N, Alonso MM, Fernandez Mentaberri MV, Zareba G, Clarkson T, Gotelli C, Gotelli M, Yan L, Treanor J. J Pediatr; 2009 Oct; 155(4):495-9. PubMed ID: 19560158 [Abstract] [Full Text] [Related]
2. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J. Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396 [Abstract] [Full Text] [Related]
3. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Lancet; 2002 Nov 30; 360(9347):1737-41. PubMed ID: 12480426 [Abstract] [Full Text] [Related]
4. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. Stajich GV, Lopez GP, Harry SW, Sexson WR. J Pediatr; 2000 May 30; 136(5):679-81. PubMed ID: 10802503 [Abstract] [Full Text] [Related]
5. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T. Environ Health Perspect; 2005 Aug 30; 113(8):1015-21. PubMed ID: 16079072 [Abstract] [Full Text] [Related]
6. Toxicokinetics of mercury after long-term repeated exposure to thimerosal-containing vaccine. Barregard L, Rekić D, Horvat M, Elmberg L, Lundh T, Zachrisson O. Toxicol Sci; 2011 Apr 30; 120(2):499-506. PubMed ID: 21252391 [Abstract] [Full Text] [Related]
7. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Rooney JP. Pediatrics; 2008 Oct 30; 122(4):902; author reply 902-3. PubMed ID: 18829819 [No Abstract] [Full Text] [Related]
8. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage. Luman ET, Fiore AE, Strine TW, Barker LE. JAMA; 2004 May 19; 291(19):2351-8. PubMed ID: 15150207 [Abstract] [Full Text] [Related]
9. Neonate exposure to thimerosal mercury from hepatitis B vaccines. Dórea JG, Marques RC, Brandão KG. Am J Perinatol; 2009 Aug 19; 26(7):523-7. PubMed ID: 19283656 [Abstract] [Full Text] [Related]
10. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan. Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G. Pediatrics; 2003 Jun 19; 111(6 Pt 1):e645-9. PubMed ID: 12777580 [Abstract] [Full Text] [Related]
11. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants. Magos L. J Appl Toxicol; 2003 Jun 19; 23(4):263-9. PubMed ID: 12884410 [Abstract] [Full Text] [Related]
12. The evidence for the safety of thiomersal in newborn and infant vaccines. Clements CJ. Vaccine; 2004 May 07; 22(15-16):1854-61. PubMed ID: 15121295 [Abstract] [Full Text] [Related]
13. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH. Pediatrics; 1999 Feb 07; 103(2):E14. PubMed ID: 9925860 [Abstract] [Full Text] [Related]
15. Identification and distribution of mercury species in rat tissues following administration of thimerosal or methylmercury. Rodrigues JL, Serpeloni JM, Batista BL, Souza SS, Barbosa F. Arch Toxicol; 2010 Nov 07; 84(11):891-6. PubMed ID: 20386881 [Abstract] [Full Text] [Related]
16. Mercury in infants given vaccines containing thiomersal. Colman E. Lancet; 2003 Feb 22; 361(9358):698; author reply 699. PubMed ID: 12606188 [No Abstract] [Full Text] [Related]
17. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content. Chang S, Begier EM, Schech SD, Venus P, Shatin D, Braun MM, Ball R. Pediatr Infect Dis J; 2007 Apr 22; 26(4):329-33. PubMed ID: 17414397 [Abstract] [Full Text] [Related]
18. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2001 Feb 16; 50(6):94-7. PubMed ID: 11263794 [Abstract] [Full Text] [Related]
19. Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Berman RF, Pessah IN, Mouton PR, Mav D, Harry J. Toxicol Sci; 2008 Feb 16; 101(2):294-309. PubMed ID: 17977901 [Abstract] [Full Text] [Related]
20. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines. Thomas AR, Fiore AE, Corwith HL, Cieslak PR, Margolis HS. Pediatr Infect Dis J; 2004 Apr 16; 23(4):313-8. PubMed ID: 15071284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]